MedPath
NMPA Approval

Amifostine for Injection

国药准字H20249418

November 22, 2024

Drug Information

注射用氨磷汀

注射剂

0.5g(按C₅H₁₅N₂O₃PS计)

化学药品

November 22, 2024

Company Information

Applicant Company

成都天府国际生物城(双流区岐黄二路1533号)

Manufacturing Company

四川省内江市市中区汉阳路333号3幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氨磷汀 - NMPA 批准文号 | MedPath